What You Should Know:

你应该知道的：

–

–

Akido Labs, Inc.

阿基多实验室公司

(“Akido”), an

（“Akido”），一个

AI

人工智能

and care delivery company dedicated to reimagining healthcare raises $60M in Series B funding led by

一家致力于重新构想医疗保健的公司完成了由...领投的6000万美元B轮融资

Oak HC/FT

橡树健康与健身中心

, with participation from

，参与方包括

Greco

希腊的

,

，

SNR

信噪比

, and existing investors including

，以及包括现有投资者在内的

Y Combinator

Y组合子

,

，

Future Communities Capital,

未来社区资本，

Jeff Dean (Chief Scientist,

杰夫·迪恩（首席科学家，

Google DeepMind

谷歌DeepMind

&

&

Google Research

谷歌研究院

), and the

），以及

Comprehensive Blood & Cancer Center

全面血液与癌症中心

.

。

– The investment will be channeled towards expanding the reach and capabilities of Akido’s innovative ScopeAI system, a platform designed to increase clinical capacity and dramatically improve healthcare access.

- 这笔投资将用于扩展Akido创新的ScopeAI系统的覆盖范围和能力，该平台旨在增加临床资源并显著改善医疗保健的可及性。

Addressing the Global Physician Deficit with ScopeAI

利用ScopeAI解决全球医生短缺问题

The U.S. healthcare system faces a significant challenge: demand for care far outstrips available physician capacity. Americans require over 3 billion doctor visits annually, yet only about 825 million are currently available, leading to long wait times, rushed appointments, and an increase in preventable diseases.

美国医疗系统面临一个重大挑战：对医疗服务的需求远远超过了医生的可用能力。美国人每年需要超过30亿次的看诊，但目前仅能提供约8.25亿次，导致预约等待时间长、就诊匆忙以及可预防疾病增加。

Akido aims to address this crisis head-on with ScopeAI..

Akido旨在通过ScopeAI直面这一危机。

“We built ScopeAI to tackle the single biggest challenge facing healthcare systems worldwide: the physician shortage,” said Prashant Samant, Co-Founder & CEO of Akido. “With demand for care far exceeding supply, AI is the key to addressing the global doctor deficit, empowering healthcare providers, and ensuring patients receive the timely, high-quality care they deserve, regardless of financial means or geography.

“我们创建ScopeAI是为了应对全球医疗系统面临的最大挑战：医生短缺，”Akido的联合创始人兼首席执行官Prashant Samant说道。“随着对医疗服务的需求远远超过供给，人工智能是解决全球医生不足问题的关键，它赋能医疗服务提供者，确保患者无论经济状况或地理位置如何，都能获得及时且高质量的医疗服务。”

At Akido, we believe exceptional healthcare is a basic human right. Our work has always focused on democratizing high quality healthcare, and this funding enables us to accelerate that mission.”.

在Akido，我们相信卓越的医疗保健是基本人权。我们的工作一直专注于普及高质量的医疗保健，这笔资金使我们能够加速实现这一使命。"

ScopeAI

范围AI

is transforming how Akido providers practice medicine by embedding powerful medical intelligence directly into the clinical workflow. This enables them to care for a significantly larger number of patients without compromising the quality of care, bringing scale, efficiency, and consistency to the front lines..

正在通过将强大的医疗智能直接嵌入临床工作流程来改变Akido提供者行医的方式。这使得他们能够在不降低护理质量的情况下照顾更多患者，为医疗前线带来规模、效率和一致性。

How ScopeAI Reimagines the Clinical Encounter

ScopeAI如何重新构想临床诊疗过程

A ScopeAI-assisted visit involves a trained Medical Assistant (MA) meeting with a patient, guided by intelligent prompts from the ScopeAI system throughout the encounter. ScopeAI utilizes advanced clinical reasoning to actively listen to the patient, adapt its inquiries in real-time, and build a comprehensive understanding of the patient’s condition..

一场由ScopeAI辅助的诊疗涉及一名训练有素的医疗助理（MA）在ScopeAI系统的智能提示引导下与患者会面。ScopeAI利用先进的临床推理来积极倾听患者的意见，实时调整其询问内容，并全面了解患者的病情。

Leveraging sophisticated scribing and auditory capabilities, ScopeAI can engage in dynamic conversation while simultaneously generating a full clinical report. This report includes a preliminary diagnosis, a proposed treatment plan, and a detailed justification log for each decision made. This allows an Akido provider to oversee a team of MAs conducting ScopeAI visits, thereby increasing access to care while enabling the supervising provider to focus their expertise on higher-acuity or more complex cases.

利用先进的书写和听觉能力，ScopeAI可以进行动态对话，同时生成完整的临床报告。该报告包括初步诊断、拟议的治疗计划以及每个决策的详细理由记录。这使得Akido的医生能够监督一组医疗助理（MAs）进行ScopeAI问诊，从而增加医疗的可及性，同时让负责监督的医生将其专业知识集中在更高危或更复杂的病例上。

Providers gain a deeper, more complete picture of a patient’s health with less time spent on documentation..

通过减少花在文档记录上的时间，医疗服务提供者能够更深入、更全面地了解患者的健康状况。

Demonstrated Impact and Strategic Expansion Plans

已证明的影响和战略扩张计划

Akido’s AI-based healthcare visits have already shown remarkable results, delivering five times more face-to-face time with patients and achieving an impressive 96 Net Promoter Score (NPS), indicating high patient satisfaction.

Akido基于人工智能的医疗访问已经显示出显著的效果，与患者面对面交流的时间增加了五倍，并取得了令人印象深刻的96净推荐值（NPS），表明患者满意度很高。

The new funding will accelerate the development and deployment of ScopeAI throughout Akido Care, Akido’s medical network which comprises 240 providers across 26 specialties in nearly 100 clinics. The investment will also support Akido’s expansion into new markets, including a recently announced first-of-its-kind healthcare program in New York City designed to address specific chronic diseases for professional rideshare and for-hire drivers..

新的资金将加速ScopeAI在Akido医疗网络（包括分布在近100家诊所的26个专业领域的240名供应商）中的开发和部署。这笔投资还将支持Akido向新市场的扩展，包括最近宣布的纽约市首个针对专业拼车和租赁司机特定慢性疾病的医疗项目。

Akido Background

Akido背景

Akido was founded in 2015 with the mission of reimagining healthcare for historically vulnerable communities by leveraging AI and machine learning. The launch of Akido Care in 2022 provided the real-world clinical environment and proprietary dataset of over 10 million patient case studies necessary to develop and refine ScopeAI through a reinforcement-loop-human-feedback (RLHF) environment.

Akido成立于2015年，旨在通过利用人工智能和机器学习重新构想针对历史上脆弱社区的医疗保健。2022年推出的Akido Care提供了现实世界的临床环境和超过1000万患者案例研究的专有数据集，这对于通过强化循环人类反馈（RLHF）环境开发和完善ScopeAI至关重要。

This continuous refinement by incorporating real-time provider feedback positions ScopeAI as one of the most sophisticated clinical AI systems available. By integrating ScopeAI into the Akido Care medical network, Akido is set to empower providers to deliver highly personalized care at an individual patient level while also scaling impactful health programs at a population level..

通过整合实时供应商反馈进行持续优化，使ScopeAI成为目前最精密的临床AI系统之一。通过将ScopeAI集成到Akido Care医疗网络中，Akido将能够帮助医疗服务提供者在个体患者层面提供高度个性化的护理，同时在群体层面扩展有影响力的健康项目。